Publications by authors named "Francesca Falcetta"

Claim this Profile
E
EASY-FIA: A Readably Usable Standalone Tool for High-Resolution Mass Spectrometry Metabolomics Data Pre-Processing.
Aurelia Morabito, Giulia De Simone, Manuela Ferrario, Francesca Falcetta, Roberta Pastorelli

Metabolites· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A methodological approach to correlate tumor heterogeneity with drug distribution profile in mass spectrometry imaging data.
Mridula Prasad, Geert Postma, Pietro Franceschi, Lavinia Morosi, Silvia Giordano, Francesca Falcetta

Gigascience· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts.
Francesca Ricci, Laura Brunelli, Roberta Affatato, Rosaria Chilà, Martina Verza, Francesca Falcetta

Ther Adv Med Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Past-in-the-Future. Peak detection improves targeted mass spectrometry imaging.
Francesca Falcetta, Lavinia Morosi, Paolo Ubezio, Silvia Giordano, Alessandra Decio

Anal Chim Acta· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.
Elisa Caiola, Francesca Falcetta, Silvia Giordano, Mirko Marabese, Marina C Garassino

J Exp Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.
Francesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, Alessandra Decio, Lucia Minoli

Int J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Homogeneity Index in Mass-Spectrometry Imaging.
Mridula Prasad, Geert Postma, Lavinia Morosi, Silvia Giordano, Raffaella Giavazzi, Francesca Falcetta

Anal Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer.
Francesca Falcetta, Francesca Bizzaro, Elisa D'Agostini, Maria Rosa Bani, Raffaella Giavazzi

Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of 3D Mass Spectrometry Imaging to TKIs.
Lavinia Morosi, Silvia Giordano, Francesca Falcetta, Roberta Frapolli, Simonetta A Licandro

Clin Pharmacol Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock.
Alice Cambiaghi, Bernardo Bollen Pinto, Laura Brunelli, Francesca Falcetta, Federico Aletti

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model.
Laura Ceriani, Mariella Ferrari, Monique Zangarini, Simonetta Andrea Licandro, Ezia Bello, Francesca Falcetta

Bioanalysis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small interfering RNA delivery through positively charged polymer nanoparticles.
Luca Dragoni, Raffaele Ferrari, Monica Lupi, Alberto Cesana, Francesca Falcetta

Nanotechnology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer.
Paolo Ubezio, Francesca Falcetta, Laura Carrassa, Monica Lupi

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic rendering of the heterogeneous cell response to anticancer treatments.
Francesca Falcetta, Monica Lupi, Valentina Colombo, Paolo Ubezio

PLoS Comput Biol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles.
Raffaele Ferrari, Monica Lupi, Francesca Falcetta, Paolo Bigini, Katia Paolella

Nanotechnology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kinetics.
Raffaele Ferrari, Claudio Colombo, Cristina Casali, Monica Lupi, Paolo Ubezio, Francesca Falcetta

Int J Pharm· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Giuseppina Della Vittoria Scarpati, Francesca Falcetta, Chiara Carlomagno, Paolo Ubezio, Sergio Marchini

Int J Radiat Oncol Biol Phys· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.
Valentina Colombo, Monica Lupi, Francesca Falcetta, Daniele Forestieri, Maurizio D'Incalci

Cancer Chemother Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis